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ORIGINAL ARTICLE

DIABETIC KETOACIDOSIS CHARACTERISTICS AND DIFFERENCES
IN TYPE 1 VERSUS TYPE 2 DIABETES PATIENTS
Muhammad Owais Rashid, Aisha Sheikh, Abdus Salam, Saad Farooq, Zareen Kiran,
Najmul Islam
Aga Khan University Hospital Karachi-Pakistan

Background: Diabetes is undoubtedly one of the most challenging health problems of the 21st
century. It is well known that diabetes once develop can lead to several complications. Diabetic
ketoacidosis (DKA) is one of the life-threatening complications of diabetes. This study was
designed to determine the frequency of DKA in diabetes patients and find out the clinical and
biochemical determinants of DKA. Methods: This descriptive study was conducted at Aga Khan
University Hospital (AKUH) Karachi, Pakistan from January 2010 to February 2016. All known
or newly diagnosed diabetic patients of >16 years of age irrespective of gender and type of
diabetes were included. Information regarding patient’s demographics, presenting symptoms,
precipitating causes of DKA, biochemical profiles and outcome at the time of discharge was
collected. Results: Majority (54.7%) had moderate and 12.4% had severe DKA at presentation.
Previous history of DKA was found higher in type 1 diabetes patients (T1DM) (14%) as compare
to (4%) type 2 diabetes patients (T2DM) (p<0.05). DKA severity was observed more (12%) in
newly diagnosed (T1DM) (p<0.05). Comorbidities were found more (81%) in (T2DM) (p<0.05)
Mortality was also observed higher in Type 2 diabetes patients (p<0.05). Conclusion: Majority of
the diabetics had moderate to severe DKA at presentation. Mortality and morbidity related with
DKA was found considerably higher among patients with T2DM while infection, myocardial
infarction and stroke found as triggering factors in these patients.
Keywords: Diabetic ketoacidosis (DKA); T1DM; T2DM
J Ayub Med Coll Abbottabad 2017;29(3):398–402

INTRODUCTION
Diabetic ketoacidosis (DKA) is a medical emergency
which was once thought to occur in only type 1
diabetes patient but has now been proven to occur in
type 2 diabetes as well. It occurs due to relative or
complete lack of insulin in the body.1–3
Its prevalence is higher among type 2
diabetes mellitus (T2DM) patients as compared to
type 1 diabetes mellitus (T1DM), and the proportion
is expected to increase over the next 20 years;
therefore, the presentation of DKA is likely to be
higher in people with T2DM.4 The overall prevalence
of ketosis-prone T2DM is comparatively lower in
Asian and white people and may represent fewer than
10% of cases of DKA.5,6
There are various parameters that need to be
ascertained in both type 1 and type 2 diabetes patients
who present with DKA, like age of presentation,
presenting clinical features, precipitating cause and
biochemical characteristics. Many studies have been
conducted to observe the characteristics of DKA in
both type 1 and type 2 diabetes mellitus2,5,7 and
various comparisons have been made worldwide but
the local data of Pakistan is still scarce. The need for
more studies is needed and justified in order to know
valuable information about ketoacidosis in Pakistani
diabetes patients. This information will help in
increasing our knowledge and understanding of
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various factors related to DKA and help in
differentiating the various characteristics of both type
1 and type 2 diabetes patients. In the present study,
we aimed to determine the frequency of DKA in
Pakistani diabetes population and comparison of
clinical and biochemical characteristics of DKA in
type 1 and type 2 diabetes.

MATERIAL AND METHODS
This retrospective study was conducted among 234
patients aged 16 years and above of either gender
admitted with diagnosis of DKA to Aga Khan
University Hospital (AKUH) Karachi, Pakistan
during the period from January 2010 to February
2016. Patients aged below 16 years and non-diabetics
presenting with ketoacidosis were excluded from the
study. Informed written consent was obtained from
hospital authorities to use the data of patients. No
personal detail by any means related to any patient
was revealed in regard of ethical considerations.
Computer coding was used to identify
admissions with an ICD code for DM and DKA
during the period of study. Diagnosis of DKA was
made by the presence of an arterial pH lower than
7.30, an anion gap of less than 15 mmol/L,
presence of hyperglycemia, i.e., blood glucose
>250mg/dL, urine ketone levels of ‘moderate’or
‘large’ i.e., equal to or more than 2+. DKA was
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classified as mild, moderate or severe according to
ADA criteria1 (see annexure). Serum osmolality
was being calculated using the formula 2[measured
Na (mEq/l)] + glucose (mg/dl)/18 and was
measured in mosm/kg. Anion gap was calculated
using the formula (Na+) − (Cl− + HCO3−)
(mEq/L).
All patients presenting with DKA were
admitted under medicine service and were
managed by team of internist, medicine residents
and interns while in emergency department and
ward.
Endocrinology
team
including
an
endocrinologist, fellow endocrinology and diabetes
nurse were later involved as specialist team. All
patients were managed as per the hospital’s local
management protocol of DKA.
Patients data was reviewed retrospectively
regarding patient’s demographics, presenting
symptoms, precipitating causes of DKA, vital
signs, biochemical profiles at presentation to the
emergency department, amount of intravenous
fluid administered, amount of insulin administered,
duration of insulin infusion, time from presentation
to resolution of urine ketones, insulin dose at
discharge, and length of hospitalization and
outcome at the time of discharge was collected.
Precipitating factors of DKA were defined as
conditions leading to the development of DKA,
such as inadequate insulin dose or missed insulin
doses, sepsis, infection, surgical stress etc. For
patient presenting with more than one factor, the
main cause was noted. Observation bias was
controlled by reconfirmation of collected
information from hospital’s records by a second
verifier. Confounding factors were rectified
through restriction.
Subjects were classified as Type 2 DM if
they had prior history of treatment (>1 years) with
diet alone or oral hypoglycaemic agents (OHA), or
as ‘new onset’ if the episode of DKA was the first
manifestation of diabetes. Patients with new-onset
DM were further classified as type 1 or type 2 if
they discontinued insulin use without recurrence of
DKA for at least 1 year respectively. Patients
follow-up data was obtained by chart review or
telephone contact when necessary.
Data was analysed by using SPSS version
19.0. Frequency and percentages were computed
for categorical variables, i.e.; gender, type and
duration of DM, previous episode of DKA,
presenting symptoms and severity of DKA. Chi
square test was used to compare the categorical
variables between T1DM versus T2DM patients.
Mean and Standard Deviation was computed for

continuous variables, i.e.; age, BMI, duration of
DM and biochemical parameters. T-test and
ANOVA were used to compare Mean±Standard
Deviation. P value less than 0.05 was considered
as significant.

RESULTS
Data of 234 patients with diabetes was used in this
study. Patients were divided into four groups,
newly diagnosed type I (n=47), known type I
(n=59), newly diagnosed type II (n=10) and known
type II (n=118). Out of total 234 patients, 120
(51.3%) were males and 114 (48.7%) were
females. Body mass index (BMI) was found
significantly more in type 2 diabetes (p<0.05).
Previous history of DKA was found more in
known type I diabetes patients (14%) as compare
to (4%) known type II diabetes patients (p<0.05).
More than half (54.7%) of the subjects had
moderate DKA and 12.4% of them had severe
DKA at presentation. DKA severity was observed
more (12%) in newly diagnosed type 1 diabetes
patients (p<0.05). Comorbidities were found more
(81%) in known type 2 diabetes patients (p<0.05)
(Table-1).
Table-2 shows the presentation of
biochemical parameters of the study participants.
Haemoglobin levels were higher in newly
diagnosed type 1 diabetes patients (p<0.001).
WBC and platelet counts were high in known type
1 diabetes patients (p<0.05).No significant
differences were found in other biochemical
parameters. (Table-2)
Figure-1 shows the presenting symptoms
of patients of type I and II diabetes. Polyphagia,
polydipsia, polyuria, weight loss and abdominal
pain was significantly higher in type 1 diabetes
patients.
The comparison of DKA treatment of type
I and type II patients are presented in Table-3. The
amount of insulin given to the type 1 and 2 patients
were same (p>0.05). Length of stay in hospital, ICU
admission and ventilator support were also not
different significantly in both groups (p>0.05).
Precipitating factors like infection, myocardial
infarction and stroke were found more in type 2
patients, while more type 1 patients were found noncompliant (p<0.05). Overall mortality due to DKA
was 9.4% (22 out of 234 patients) and was higher in
type 2 patients (p<0.05). Six out of 47 (12.8%) newly
diagnosed type 1 patients and 16 out of 118 (13.6%)
known type 2 diabetic patients had mortality due to
DKA (p<0.05).
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Figure-1: Presenting symptoms of type 1 and type 2 patients.
Other included Fits, cough, diarrhoea and nausea. Only moderate and severe altered mental status is presented.
*p<0.05, **p<0.0001

Table-1: Baseline characteristics of the study groups
Newly diagnosed Type 1
47
31.7±13.2

Known type 1
59
31.6±12.6

Newly diagnosed Type 2
10
55.6±14.1

Known type 2
118
57.0±12.3

61.7 (29)
38.3(18)
0.06±0.44
97.9 (46)
2.1 (1)
----21.3±5.5
0 (0)

39 (23)
61 (36)
8.3±7.9
3.4 (2)
47.5 (28)
18.6 (11)
30.5 (18)
22.0±4.3
23.7 (14)

70 (7)
30 (3)
--100 (10)
------22.1±1.49
0 (0)

51.7(61)
48.3(57)
9.9±8.4
21.2 (25)
14.4 (17)
22 (26)
42.4 (50)
26.7±7.6
3.4 (4)

21.3 (10)
53.2 (25)
25.5 (12)
18.8 (9)

28.8 (17)
59.3 (35)
11.9 (7)
28.8(17)

30 (3)
60 (6)
10 (1)
50 (5)

39.8 (47)
52.5 (62)
7.6 (9)
68.6 (81)

Number of patients
Age (years)
Sex
Male
Female
Duration of diabetes (years)
Less than a year
1-5 years
6-10 years
>10 years
BMI (kg/m²)
Previous episodes of DKA
Severity of DKA
Mild
Moderate
Severe
Comorbidities
Data presented as Mean±Sd and %(n)

Table-2: Biochemical characteristics of subgroups of patients with DKA
Haemoglobin (gm/dl)
WBC Count (x10E9/L)
Platelet Count (x10E9/L)
BUN (mg/dl)
Creatinine (mg/dl)
Sodium (mmol/L)
Potassium (mmol/L)
Chloride (mmol/L)
Bicarbonate (mmol/L)
Arterial pH
PCO2 (mmHg)
PO2 (mmHg)
O2 Saturation (%)
Amylase
Lipase
Urinary Ketones
Random Blood Sugar
Serum osmolality (mosm/Kg)
Anion Gap
HBA1C %
Data presented as Mean±SD
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Newly diagnosed
Type 1
13.8±2.5
13.7±7.1
256.3±121.9
23.2±23.6
1.7±2.2
133.4±9
4.1±1
99.3±10.8
8.7±4.6
7.2±0.2
22.6±9.4
130.4±81.8
92.6±12.6
120.5±109.7
155.6±175.2
2.7±0.4
513.9±210.3
304.4±31.6
25.3±6.4
12.3±3

Known type 1
diabetes
13.1±1.9
18±8.8
339.6±143.8
23.2±17.1
1.6±1.4
132±7.8
4.8±1.2
97.4±10.4
9.8±5.4
7.2±0.1
20.6±7.3
124.3±83
92.2±15.5
291.7±488.8
155.4±282.5
2.7±0.5
490.6±203.3
303.6±24.5
25.5±7.4
11.9±2.8
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Newly diagnosed type
2
13.5±2.5
12.7±4.9
231.6±104
20.8±12.1
1.6±0.5
134.2±6.7
4.5±0.8
98.9±6
10.4±3.5
7.2±0.1
28.6±12.3
79.1±44.7
80.3±27.1
147.5±38.9
84±22.6
2.5±0.5
517.5±156.8
310.7±29.5
24.9±7.1
12.8±2.3

Known type 2
diabetes
11.9±2.5
16.3±6.7
306.8±145.3
40.4±28.2
2.3±1.9
130.9±8.8
4.9±1.1
96.5±9.5
11.6±4.7
7.2±0.1
25.3±9.3
120.1±73.7
92.4±11.7
215.1±290.6
208.2±502.3
2.4±0.7
485.6±176.7
303.5±28.4
23.1±7.2
10.7±2.7
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Table3: Mode of severity and outcome of DKA in type 1 and type 2 diabetes
Characteristic
Severity of DKA
Mild
Moderate
Sever
Amount of Insulin (units per hour)
Length of stay (days)
Admission in ICU
Ventilator support
Precipitating factors
Infection
Non-compliance
Myocardial Infarction
Stroke
Other
Mortality

Type 1(n=106)

Type 2 (n=128)

p-value

Total

25.5(27)
56.6(60)
17.9(19)
152.4±224.9
5.92±8.8
24.5 (26)
20.8 (22)

39.1 (50)
53.1 (68)
7.8(10)
141.3±159.8
5.92±5.3
30.5 (39)
28.1 (36)

0.017

32.9 (77)
54.7 (128)
12.4 (29)
146.5±192.8
5.92±7.08
27.8 (65)
24.8 (58)

20.8 (22)
25.5 (27)
0.9 (1)
0.9 (1)
51.9 (55)
5.7 (6)

49.2 (63)
10.2 (13)
7.8 (10)
3.1 (4)
29.7 (38)
12.5 (16)

<0.0001

DISCUSSION
As highlighted earlier the aim of this study was to
determine the prevalence, mortality and morbidity
associated with DKA. The finding of this study has
revealed that all diabetic patients irrespective of type
of diabetes are at risk of being hospitalized with
DKA. This finding is supported by similar previous
study as well.8
In our study, T1DM was predominantly
higher among middle aged patients whereas T2DM
was highly prevalent in older patients (mostly above
fifty-five years of age). This finding is also supported
by other studies.8–10 Studies also reported that
atypical diabetes with ketosis also widely exist
worldwide.10,11
The average length of stay in our study was
6 days. Moreover, there was insignificant difference
in length of stay of among patients with T1DM and
T2DM. This finding was found higher when
compared with a study conducted in USA but lower
when compared with a study conducted in China.8,12
Overall mortality was found to be
considerably higher in our cohort as compared to
various studies conducted in different regions of the
world.8,9,13–15
In
particular,
mortality
was
predominantly higher in patients with T2DM. The
higher mortality rate in T2DM may be due the reason
that T2DM is highly prevalent in our region. Most of
the patients with T2DM presented with multiple
complications which is supported by the evidence
that precipitating factors like infections, myocardial
infection and stroke was significantly higher among
patients with T2DM.
It is reported that DKA can be caused when
patients forget or knowingly do not take diabetic
medications or they may have developed a secondary
condition such as infection, myocardial infarction,
stroke, pancreatitis etc. which results in increased
demand or insufficient levels of insulin in the body. It
can also occur when diabetic patients take

0.252
0.106
0.313
0.194

0.013

36.3 (85)
17.1 (40)
4.7 (11)
2.1 (5)
39.7 (93)
9.4 (22)

medications such as corticosteroids.1,2 Several
complications also occurred during the treatment of
DKA.3,16–21

CONCLUSION
Majority of the patients had moderate to severe DKA
at presentation. Mortality and morbidity related with
DKA was found considerably higher among patients
with T2DM while infection, myocardial infarction
and stroke found as triggering factors in these
patients.
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